2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| BIOS Fund II NT, LP | 10% Owner | 6,000,000 | Jun 11, 2024 |
| Kreis Leslie W. | Director | 6,000,000 | Jun 11, 2024 |
| Cavu Management, LP | 10% Owner | 6,000,000 | Jun 11, 2024 |
| Cavu Advisors, LLC | 10% Owner | 6,000,000 | Jun 11, 2024 |
| BP Directors, LP | — | 6,000,000 | Jun 11, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | Feb 18, 2026 | Ricciardi Lisa | CEO | Sell | 52.5 | -5,850 | -0.33% | ✗ | $6.6K |
| Feb 15, 2026 | Feb 18, 2026 | Doyle John Brendan | CFO | Sell | 52.5 | -1,560 | -0.25% | ✗ | $1.7K |
| Feb 15, 2026 | Feb 18, 2026 | Caggiano Anthony | Chief Medical Officer | Sell | 50.0 | -4,680 | -0.54% | ✗ | $5.2K |
| Feb 3, 2026 | Feb 5, 2026 | Ricciardi Lisa | CEO | Sell | 95.0 | +722,260 | 70.18% | ✗ | $82.4K |
| Feb 3, 2026 | Feb 5, 2026 | Doyle John Brendan | CFO | Sell | 91.3 | +173,079 | 38.81% | ✗ | $27.7K |
| Feb 3, 2026 | Feb 5, 2026 | Caggiano Anthony | Chief Medical Officer | Sell | 91.3 | +361,593 | 71.18% | ✗ | $40.6K |
| Dec 18, 2025 | Dec 22, 2025 | Ricciardi Lisa | CEO | Sell | 86.3 | +51,600 | 5.28% | ✗ | $35.1K |
| Dec 18, 2025 | Dec 22, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 86.3 | +44,720 | 9.65% | ✗ | $30.4K |
| Dec 18, 2025 | Dec 22, 2025 | Doyle John Brendan | CFO | Sell | 83.8 | +20,640 | 4.85% | ✗ | $14K |
| Sep 19, 2025 | Sep 23, 2025 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 29, 2025 | Jul 31, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 91.3 | +44,719 | 10.68% | ✗ | $13.6K |
| Jul 29, 2025 | Jul 31, 2025 | Doyle John Brendan | CFO | Sell | 85.0 | +20,640 | 5.10% | ✗ | $6.3K |
| Jul 29, 2025 | Jul 31, 2025 | Ricciardi Lisa | CEO | Sell | 86.3 | +51,600 | 5.57% | ✗ | $15.7K |
| Jun 18, 2025 | Jun 23, 2025 | Khattar Jack A. | Director | Neutral | 90.0 | +34,000 | 234.48% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | Wallace Peggy | Director | Neutral | 90.0 | +34,000 | 64.81% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | RICHSTONE ELLEN B | Director | Neutral | 90.0 | +34,000 | 138.78% | ✗ | - |
| Jun 18, 2025 | Jun 23, 2025 | Monia Brett P | Director | Neutral | 90.0 | +34,000 | 234.48% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Kreis Leslie W. | Director | Neutral | 67.5 | +34,000 | 0.57% | ✗ | - |
| Jun 18, 2025 | Jun 20, 2025 | Fletcher Aaron G.L. | Director | Neutral | 67.5 | +34,000 | 0.57% | ✗ | - |
| May 1, 2025 | May 2, 2025 | Doyle John Brendan | CFO | Sell | 47.5 | -9,692 | -2.34% | ✗ | $4.3K |
| Feb 15, 2025 | Feb 18, 2025 | Ricciardi Lisa | CEO | Sell | 50.0 | -6,619 | -0.74% | ✗ | $3.9K |
| Feb 15, 2025 | Feb 18, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 47.5 | -5,296 | -1.25% | ✗ | $3.1K |
| Feb 15, 2025 | Feb 18, 2025 | Doyle John Brendan | CFO | Sell | 52.5 | -1,723 | -0.41% | ✗ | $1K |
| Feb 3, 2025 | Feb 4, 2025 | Caggiano Anthony | Chief Medical Officer | Sell | 90.0 | +282,221 | 199.27% | ✗ | $8.5K |
| Feb 4, 2025 | Feb 4, 2025 | Doyle John Brendan | CFO | Neutral | 90.0 | +295,000 | 243.55% | ✗ | - |
| Jan 31, 2025 | Feb 4, 2025 | Ricciardi Lisa | CEO | Buy | 91.3 | +641,191 | 220.08% | ✗ | $10.7K |
| Jun 7, 2024 | Jun 11, 2024 | Kreis Leslie W. | Director | Neutral | 55.0 | +8,500 | 0.14% | ✗ | - |
| Jun 7, 2024 | Jun 11, 2024 | Fletcher Aaron G.L. | Director | Neutral | 55.0 | +8,500 | 0.14% | ✗ | - |
| Jun 7, 2024 | Jun 11, 2024 | Wallace Peggy | Director | Neutral | 90.0 | +8,500 | 19.34% | ✗ | - |
| Jun 7, 2024 | Jun 11, 2024 | Khattar Jack A. | Director | Neutral | 90.0 | +8,500 | 141.67% | ✗ | - |
| Jun 7, 2024 | Jun 11, 2024 | RICHSTONE ELLEN B | Director | Neutral | 90.0 | +8,500 | 53.13% | ✗ | - |
| Jun 7, 2024 | Jun 11, 2024 | Monia Brett P | Director | Neutral | 90.0 | +8,500 | 141.67% | ✗ | - |
| May 1, 2024 | May 3, 2024 | Doyle John Brendan | CFO | Sell | 46.3 | -8,699 | -6.70% | ✗ | $17K |
| Mar 14, 2024 | Mar 14, 2024 | Ricciardi Lisa | CEO | Buy | 77.5 | +5,700 | 2.00% | ✗ | $10K |
| Feb 15, 2024 | Feb 20, 2024 | Doyle John Brendan | CFO | Neutral | 90.0 | +20,000 | 18.21% | ✗ | - |
| Feb 15, 2024 | Feb 20, 2024 | Caggiano Anthony | Chief Medical Officer | Neutral | 90.0 | +60,000 | 73.50% | ✗ | - |
| Feb 15, 2024 | Feb 20, 2024 | Ricciardi Lisa | CEO | Neutral | 90.0 | +75,000 | 35.60% | ✗ | - |
| Feb 3, 2024 | Feb 9, 2024 | Caggiano Anthony | Chief Medical Officer | Sell | 46.3 | -12,777 | -13.53% | ✗ | $29.3K |
| Feb 3, 2024 | Feb 9, 2024 | Ricciardi Lisa | CEO | Sell | 42.5 | -27,828 | -11.67% | ✗ | $63.7K |
| Nov 13, 2023 | Bios Clinical Opportunity Fund, LP | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 8, 2023 | Nov 13, 2023 | Kreis Leslie W. | Director | Neutral | 85.0 | +500,095 | 9.08% | ✗ | - |
| Nov 8, 2023 | Nov 13, 2023 | Fletcher Aaron G.L. | Director | Neutral | 85.0 | +500,095 | 9.08% | ✗ | - |
| Jun 9, 2023 | Jun 13, 2023 | Kreis Leslie W. | Director | Neutral | 55.0 | +6,000 | 0.11% | ✗ | - |
| Jun 9, 2023 | Jun 13, 2023 | Fletcher Aaron G.L. | Director | Neutral | 55.0 | +6,000 | 0.11% | ✗ | - |
| Jun 9, 2023 | Jun 13, 2023 | Monia Brett P | Director | Neutral | 90.0 | +6,000 | 100.00% | ✗ | - |
| Jun 9, 2023 | Jun 13, 2023 | Wallace Peggy | Director | Neutral | 90.0 | +6,000 | 15.81% | ✗ | - |
| Jun 9, 2023 | Jun 13, 2023 | RICHSTONE ELLEN B | Director | Neutral | 90.0 | +6,000 | 60.00% | ✗ | - |
| Jun 9, 2023 | Jun 13, 2023 | Khattar Jack A. | Director | Neutral | 90.0 | +6,000 | 100.00% | ✗ | - |
| May 1, 2023 | May 3, 2023 | Doyle John Brendan | CFO | Neutral | 90.0 | +109,824 | 100.00% | ✗ | - |
| May 3, 2023 | Doyle John Brendan | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 3, 2023 | Feb 7, 2023 | Caggiano Anthony | Chief Medical Officer | Neutral | 90.0 | +94,406 | 100.00% | ✗ | - |
| Feb 3, 2023 | Feb 7, 2023 | Ricciardi Lisa | CEO | Neutral | 90.0 | +213,973 | 873.36% | ✗ | - |
| Nov 29, 2022 | Nov 29, 2022 | RICHSTONE ELLEN B | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $26.6K |
| Nov 28, 2022 | Nov 29, 2022 | Fletcher Aaron G.L. | Director | Buy | 61.3 | +16,064 | 0.29% | ✗ | $42.6K |
| Nov 28, 2022 | Nov 29, 2022 | Kreis Leslie W. | Director | Buy | 61.3 | +16,064 | 0.29% | ✗ | $42.6K |
| Nov 16, 2022 | Nov 17, 2022 | Fletcher Aaron G.L. | Director | Buy | 82.5 | +71,000 | 1.31% | ✗ | $99.4K |
| Nov 16, 2022 | Nov 17, 2022 | Kreis Leslie W. | Director | Buy | 82.5 | +71,000 | 1.31% | ✗ | $99.4K |
| Nov 15, 2022 | Nov 16, 2022 | Ricciardi Lisa | CEO | Buy | 91.3 | +12,000 | 96.00% | ✗ | $15.6K |
| Nov 15, 2022 | Nov 16, 2022 | Wallace Peggy | Director | Buy | 91.3 | +12,500 | 49.09% | ✗ | $15K |
| Nov 15, 2022 | Nov 16, 2022 | Fletcher Aaron G.L. | Director | Buy | 100.0 | +1,500,000 | 38.34% | ✗ | $1.8M |
| Nov 15, 2022 | Nov 16, 2022 | Kreis Leslie W. | Director | Buy | 100.0 | +1,500,000 | 38.34% | ✗ | $1.8M |
| Sep 27, 2022 | Sep 29, 2022 | Golden Seeds Cognition Therapeutics LLC | 10% Owner | Neutral | 27.5 | -2,489,682 | -100.00% | ✗ | - |
| Sep 27, 2022 | Sep 29, 2022 | Wallace Peggy | Director | Neutral | 90.0 | +22,461 | 748.70% | ✗ | - |
| Aug 15, 2022 | Einhorn Andrew J. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 10, 2022 | Jun 30, 2022 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 23, 2022 | Monia Brett P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 23, 2022 | RICHSTONE ELLEN B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 23, 2022 | Khattar Jack A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 23, 2022 | Wallace Peggy | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 23, 2022 | Ricciardi Lisa | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 14, 2022 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 13, 2022 | Ricciardi Lisa | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 13, 2022 | Wallace Peggy | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 13, 2022 | RICHSTONE ELLEN B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 13, 2022 | Monia Brett P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2022 | Jun 13, 2022 | Khattar Jack A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 23, 2022 | Mar 25, 2022 | Caggiano Anthony | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 23, 2022 | Mar 25, 2022 | O'Brien James Michael | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 31, 2022 | Feb 1, 2022 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2022 | BP Directors, LP | Other | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Feb 1, 2022 | BIOS Memory SPV I, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 13, 2021 | Feb 1, 2022 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2022 | BIOS Memory SPV I, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 1, 2022 | Fletcher Aaron G.L. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 1, 2021 | Nov 10, 2021 | Caggiano Anthony | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 10, 2021 | Caggiano Anthony | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 1, 2021 | Nov 3, 2021 | RICHSTONE ELLEN B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 3, 2021 | RICHSTONE ELLEN B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 13, 2021 | Oct 25, 2021 | Wallace Peggy | Director | Buy | 91.3 | +3,000 | 100.00% | ✗ | $36K |
| Oct 13, 2021 | Oct 15, 2021 | BIOS Memory SPV I, LP | 10% Owner | Buy | 100.0 | +189,909 | 15.31% | ✗ | $2.3M |
| Oct 13, 2021 | Oct 15, 2021 | Fletcher Aaron G.L. | Director | Buy | 100.0 | +189,909 | 15.31% | ✗ | $2.3M |
| Oct 13, 2021 | Oct 15, 2021 | Golden Seeds Cognition Therapeutics LLC | 10% Owner | Sell | 52.5 | -33 | 0.00% | ✗ | $397.1 |
| Oct 13, 2021 | Oct 15, 2021 | Ogden CAP Associates, LLC | 10% Owner | Sell | 52.5 | -74 | 0.00% | ✗ | $888.6 |
| Oct 13, 2021 | Oct 15, 2021 | Breedlove Mark H. | Director | Sell | 52.5 | -11 | 0.00% | ✗ | $140.9 |
| Oct 13, 2021 | Oct 14, 2021 | Ricciardi Lisa | CEO | Buy | 95.0 | +12,500 | 100.00% | ✗ | $150K |
| Oct 13, 2021 | Oct 14, 2021 | O'Brien James Michael | CFO | Buy | 95.0 | +5,000 | 100.00% | ✗ | $60K |
| Oct 7, 2021 | Oct 12, 2021 | Ricciardi Lisa | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 7, 2021 | Oct 12, 2021 | O'Brien James Michael | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 7, 2021 | BIOS Memory SPV I, LP | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 7, 2021 | Golden Seeds Cognition Therapeutics LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |